glycopyrrolate

FDA Drug Profile — GLYCOPYRROLATE, Glycopyrrolate, glycopyrrolate, Cuvposa, GLYRX-PF

glycopyrrolate is listed in the FDA National Drug Code directory with 50 NDC codes, marketed under brand names including GLYCOPYRROLATE, Glycopyrrolate, glycopyrrolate. Available dosage forms: injection, tablet, injection, solution, liquid, solution.

Drug details

Generic Name
glycopyrrolate
Brand Names
GLYCOPYRROLATE, Glycopyrrolate, glycopyrrolate, Cuvposa, GLYRX-PF
Application Number
ANDA210927
Sponsor
Solco Healthcare US, LLC
NDC Codes
50
Dosage Forms
INJECTION, TABLET, INJECTION, SOLUTION, LIQUID, SOLUTION
Routes
INTRAMUSCULAR, INTRAVENOUS, ORAL
Active Ingredients
GLYCOPYRROLATE

Indications and Usage

1 INDICATIONS AND USAGE Glycopyrrolate Oral Solution is indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). Glycopyrrolate Oral Solution is an anticholinergic indicated to reduce chronic severe drooling in patients aged 3-16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.